Inotiv shares surge 16.32% premarket after preliminary approval of derivative settlement agreement.

Inotiv (NASDAQ:NOTV) surged 16.32% in premarket trading, driven by its announcement of preliminary approval for a derivative settlement agreement, reported on February 4, 2026, and a February 6, 2025, update highlighting improved natural health product (NHP) strategies and revenue growth targets for fiscal 2025. The settlement resolution likely alleviated regulatory uncertainties, while the strategic outlook reinforced confidence in the company’s operational turnaround. Despite a lowered price target by Craig-Hallum and a Q1 earnings miss reported earlier in the week, the positive developments overshadowed near-term challenges, prompting premarket buying.